Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Supergroup (SGP)

Supergroup
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:SGP
DateTimeSourceHeadlineSymbolCompany
01/11/200922:00PR Newswire (US)Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) AnnLSE:SGP
30/10/200918:12PR Newswire (US)U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant MelanomaLSE:SGP
30/10/200913:31PR Newswire (US)Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco, and American Eagle Released by Seven Summits ResearchLSE:SGP
29/10/200922:11Dow Jones NewsPriceline.com To Replace Schering-Plough In S&P 500 IndexLSE:SGPSchering-Plough Corp.
29/10/200921:24Dow Jones NewsUPDATE: US FTC Clears Merck-Schering Deal, With ConditionsLSE:SGPSchering-Plough Corp.
29/10/200920:43Dow Jones NewsUS FTC Clears Merck-Schering Deal, With ConditionsLSE:SGPSchering-Plough Corp.
19/10/200913:58Dow Jones NewsJ&J, Schering Arthritis Drug Shows Success In Stopping DamageLSE:SGPSchering-Plough Corp.
15/10/200913:30PR Newswire (US)Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and PEGINTRON(R) Data at the American Association for the Study LSE:SGP
14/10/200905:58Dow Jones NewsAustralian Regulator Oks Schering-Plough Acquisition Of MerckLSE:SGPSchering-Plough Corp.
08/10/200913:37PR Newswire (US)Intervet/Schering-Plough Animal Health Announces Sponsorship Supporting Milk Producers In MalawiLSE:SGP
07/10/200916:49Dow Jones NewsDoctors, Drug Executives Say Reform Won't Cure Health Care's IllsLSE:SGPSchering-Plough Corp.
07/10/200914:31PR Newswire (US)Critical Alerts for Microsoft, Schering-Plough, Yamana Gold, Whole Foods, and Chalco Released by Seven Summits ResearchLSE:SGP
06/10/200920:17Dow Jones NewsSchering CEO Warns Of Loss Of Innovation In Drug Cos' DealsLSE:SGPSchering-Plough Corp.
05/10/200918:49Dow Jones NewsUPDATE: FDA Panel Narrowly Backs Schering's Pegintron For MelanomaLSE:SGPSchering-Plough Corp.
05/10/200917:16Dow Jones NewsFDA Panel Narrowly Backs Schering's Pegintron For MelanomaLSE:SGPSchering-Plough Corp.
28/09/200914:01Dow Jones NewsMerck To Sell CSL's Flu Vaccine In US Starting Next YearLSE:SGPSchering-Plough Corp.
23/09/200919:43Dow Jones NewsSchering's Hassan Stresses Innovation In Success For PharmaLSE:SGPSchering-Plough Corp.
21/09/200923:39Dow Jones NewsBoehringer Ingelheim To Acquire Wyeth's Animal Health AssetsLSE:SGPSchering-Plough Corp.
14/09/200922:02Dow Jones NewsSchering, Merck Spent $60 Million On Medical Education For DoctorsLSE:SGPSchering-Plough Corp.
10/09/200923:34Dow Jones NewsJ&J's Centocor Unit Gets FDA Response Letter On DoxilLSE:SGPSchering-Plough Corp.
03/09/200909:31Dow Jones NewsCORRECT: Dainippon Sumitomo In Talks To Buy SepracorLSE:SGPSchering-Plough Corp.
03/09/200905:39Dow Jones News2nd UPDATE: Dainippon Sumitomo In Talks To Buy SepracorLSE:SGPSchering-Plough Corp.
03/09/200904:10Dow Jones NewsUPDATE: Dainippon Sumitomo In Talks To By SepracorLSE:SGPSchering-Plough Corp.
01/09/200900:13Dow Jones NewsUPDATE: US Court Denies Schering-Plough $473 Million Tax RefundLSE:SGPSchering-Plough Corp.
31/08/200923:28Dow Jones NewsUS Court Denies Schering-Plough $473 Million Tax RefundLSE:SGPSchering-Plough Corp.
31/08/200918:59Dow Jones NewsUPDATE: Merck Names New Management Team For Combined CoLSE:SGPSchering-Plough Corp.
31/08/200914:44Dow Jones NewsMerck Names New Management Team For Combined Co.LSE:SGPSchering-Plough Corp.
30/08/200913:27Dow Jones NewsSanofi-Aventis Reports Phase II Trial Success For OtamixibanLSE:SGPSchering-Plough Corp.
14/08/200916:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedLSE:SGPSchering-Plough Corp.
14/08/200913:00Dow Jones NewsFDA OKs Schering-Plough Drug For Schizophrenia, BipolarLSE:SGPSchering-Plough Corp.
 Showing the most relevant articles for your search:LSE:SGP